⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ALVO News
Alvotech Ordinary Shares
Alvotech Announces Financial Results for the Nine Months to September 30, 2026, with a Business Update
globenewswire.com
ALVO
Alvotech Announces Financial Results for the Nine Months to September 30, 2026, with a Business Update
globenewswire.com
ALVO
Alvotech to Present at Upcoming Investor Conferences in November
globenewswire.com
ALVO
Alvotech to Present at Upcoming Investor Conferences in November
globenewswire.com
ALVO
Alvotech to Report Financial Results for the Nine-Month Period to September 30, 2026
globenewswire.com
ALVO
Alvotech to Report Financial Results for the Nine-Month Period to September 30, 2026
globenewswire.com
ALVO
Alvotech receives FDA approval for new SIMLANDI® manufacturing process that more than doubles output per batch
globenewswire.com
ALVO
Alvotech Receives FDA Approval for New SIMLANDI® Manufacturing Process That More Than Doubles Output Per Batch
globenewswire.com
ALVO
Alvotech and Advanz Pharma announce first known regulatory submission worldwide for proposed biosimilar to Eylea® 8 mg
globenewswire.com
ALVO
REGN
Alvotech and Advanz Pharma announce first known regulatory submission worldwide for proposed biosimilar to Eylea® 8 mg
globenewswire.com
ALVO